Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

KIDS Insider Trading

ORTHOPEDIATRICS CORP | Surgical & Medical Instruments & Apparatus

Comprehensive Trading Performance Summary

The investment history of corporate insiders at ORTHOPEDIATRICS CORP provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Surgical & Medical Instruments & Apparatus sector.

Last 7 Days
$0
Buys
$0
Sells
Last 30 Days Trend
$0
Buys
$0
Sells

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2021-05-12 15:29 2021-05-10 Schlotterback Terry D Director SELL $63.03 4,700 $296,241 2,546 -64.9%
2021-05-06 20:52 2021-05-06 Berry Bernie B III Director SELL $60.00 3,209 $192,540 24,481 -11.6%
2021-05-04 21:41 2021-05-03 Odle Gregory A Officer - Executive Vice President SELL $60.20 3,750 $225,750 66,467 -5.3%
2021-05-04 21:41 2021-05-03 Berry Bernie B III Director SELL $60.15 4,791 $288,179 27,690 -14.8%
2021-03-18 23:47 2021-03-18 Pritzker Jennifer N. 10% owner BUY $45.03 1,400 $63,041 8,000 +21.2%
2021-03-17 17:00 2021-03-15 Pelizzon David R Director BUY $46.50 3,700 $172,050 20,900 +21.5%
2021-03-17 16:59 2021-03-15 Ruf Harold Director BUY $46.98 2,880 $135,302 18,580 +18.3%
2021-03-17 16:59 2021-03-16 Infante (Reynolds) Marie C Director SELL $45.78 700 $32,046 3,902 -15.2%
2021-03-03 19:03 2021-03-01 Gerritzen Daniel J Officer - General Counsel and Secretary SELL $55.85 2,633 $147,053 29,004 -8.3%
2021-03-03 19:03 2021-03-01 Hite Fred Director, Officer - COO and CFO SELL $55.87 4,310 $240,800 63,686 -6.3%
2021-03-03 19:03 2021-03-01 Odle Gregory A Officer - Executive Vice President SELL $55.88 8,193 $457,825 64,288 -11.3%
2021-03-03 19:03 2021-03-01 Throdahl Mark C Director, Officer - CEO SELL $55.88 5,097 $284,820 146,460 -3.4%
2021-03-03 19:02 2021-03-01 Bailey David R Officer - President SELL $55.84 4,769 $266,301 88,373 -5.1%
2021-03-01 17:57 2021-02-25 Berry Bernie B III Director SELL $57.00 699 $39,843 32,481 -2.1%
2021-02-23 23:34 2021-02-22 Berry Bernie B III Director SELL $57.09 1,600 $91,344 33,180 -4.6%
2021-02-22 20:56 2021-02-19 Odle Gregory A Officer - Executive Vice President SELL $56.50 3,750 $211,875 72,481 -4.9%
2021-02-22 20:56 2021-02-19 Berry Bernie B III Director SELL $57.16 1,701 $97,229 34,780 -4.7%
2021-02-19 20:44 2021-02-18 Berry Bernie B III Director SELL $54.07 4,000 $216,280 36,481 -9.9%
2021-02-09 20:01 2021-02-05 Throdahl Mark C Director, Officer - President and CEO SELL $50.34 12,651 $636,851 151,557 -7.7%
2021-02-05 17:25 2021-02-04 Throdahl Mark C Director, Officer - President and CEO SELL $50.18 7,349 $368,773 164,208 -4.3%
2021-01-28 18:18 2021-01-27 Odle Gregory A Officer - Executive Vice President SELL $51.63 3,750 $193,613 76,231 -4.7%
2021-01-28 18:17 2021-01-27 Berry Bernie B III Director SELL $51.73 3,136 $162,225 40,481 -7.2%
2020-12-28 19:03 2020-12-23 Odle Gregory A Officer - Executive Vice President SELL $46.19 3,750 $173,213 79,981 -4.5%
2020-11-12 21:23 2020-11-10 Gerritzen Daniel J Officer - General Counsel and Secretary SELL $47.04 8,000 $376,320 31,637 -20.2%
2020-11-12 21:23 2020-11-10 Burns Stephen F Director SELL $49.29 7,000 $345,030 10,862 -39.2%
2020-11-11 00:06 2020-11-09 Burns Stephen F Director SELL $47.74 8,000 $381,890 17,862 -30.9%
2020-06-29 22:43 2020-06-25 Throdahl Mark C Director, Officer - President and CEO SELL $42.88 13,389 $574,120 171,557 -7.2%
2020-05-29 16:43 2020-05-27 Schlotterback Terry D Director SELL $44.00 7,000 $308,023 10,498 -40.0%
2020-05-29 16:43 2020-05-28 Berry Bernie B III Director SELL $46.75 1,000 $46,750 41,547 -2.4%
2020-05-28 16:48 2020-05-26 Berry Bernie B III Director SELL $47.50 1,263 $59,993 42,547 -2.9%
2020-05-27 17:20 2020-05-26 Burns Stephen F Director SELL $46.58 5,000 $232,880 25,862 -16.2%
2020-05-26 22:51 2020-05-21 Berry Bernie B III Director SELL $45.71 1,000 $45,710 43,810 -2.2%
2020-05-26 22:50 2020-05-21 Burns Stephen F Director SELL $46.31 5,000 $231,530 30,862 -13.9%
2020-05-21 23:28 2020-05-21 Odle Gregory A Officer - Executive Vice President OPT+S $45.92 8,442 $387,661 83,731 0.0%
2020-05-21 23:27 2020-05-20 Bailey David R Officer - Executive Vice President OPT+S $46.55 6,432 $299,410 93,142 0.0%
2020-05-21 23:27 2020-05-20 Throdahl Mark C Director, Officer - President and CEO OPT+S $46.56 1,876 $87,350 154,946 0.0%
2019-12-13 21:23 2019-12-13 Bailey David R Officer - Executive Vice President SELL $34.31 15,000 $514,650 85,093 -15.0%
2019-12-13 21:22 2019-12-13 Throdahl Mark C Director, Officer - President and CEO SELL $34.31 10,000 $343,100 144,897 -6.5%
2019-12-13 21:22 2019-12-13 Odle Gregory A Officer - Executive Vice President SELL $34.31 15,000 $514,650 76,194 -16.4%
2019-12-13 21:21 2019-12-13 Hite Fred Director, Officer - Chief Financial Officer SELL $34.31 10,000 $343,100 48,947 -17.0%
2018-09-14 21:08 2018-09-13 Unger Kevin Director OPT+S $33.22 1,000 $33,220 1,400 0.0%
2018-09-06 22:47 2018-09-05 Gerritzen Daniel J Officer - General Counsel and Secretary OPT+S $33.73 9,525 $321,255 23,218 0.0%
2018-05-24 21:44 2018-05-22 Pelizzon David R Director BUY $19.50 2,000 $39,000 13,000 +18.2%
2018-04-16 22:34 2018-04-13 Throdahl Mark C Director, Officer - President and CEO SELL $17.92 27,549 $493,678 141,651 -16.3%
2018-04-16 22:33 2018-04-13 Hite Fred Director, Officer - Chief Financial Officer SELL $17.92 29,471 $528,120 47,529 -38.3%
2018-04-16 22:33 2018-04-13 Gerritzen Daniel J Officer - General Counsel and Secretary SELL $17.92 11,145 $199,718 23,218 -32.4%
2018-04-16 22:32 2018-04-13 Odle Gregory A Officer - Executive Vice President SELL $17.92 33,161 $594,245 81,679 -28.9%
2018-04-16 22:31 2018-04-13 Bailey David R Officer - Executive Vice President SELL $17.92 30,231 $541,740 104,764 -22.4%
2018-03-14 00:09 2018-03-12 Berry Bernie B III Director BUY $18.07 3,747 $67,708 42,010 +9.8%
2018-03-14 00:09 2018-03-12 Pelizzon David R Director BUY $17.50 1,000 $17,500 11,000 +10.0%
SHOW ENTRIES
51-100 OF 112

How to Interpret $KIDS Trades

Not every insider transaction in ORTHOPEDIATRICS CORP is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $KIDS shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for KIDS

Insider activity data for ORTHOPEDIATRICS CORP is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $KIDS, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.